Borrelia Burgdorferi IgM At in Cerebrospinal Fluid

The Borrelia Burgdorferi IgM At test in cerebrospinal fluid is used to detect IgM antibodies against the Borrelia Burgdorferi bacterium in cerebrospinal fluid (CSF). This test is essential for diagnosing Lyme disease, which is transmitted through tick bites.

Why is this test important?

Lyme disease is becoming more prevalent in humid and forested areas worldwide. It’s estimated that up to 30% of the population could be infected. This test allows for the early detection of the disease and timely treatment. While Lyme disease is generally not fatal, if left untreated, it can lead to a variety of health issues, particularly neurological and rheumatoid complications.

How is the test performed?

The Borrelia Burgdorferi IgM antibody test in cerebrospinal fluid involves collecting a sample of cerebrospinal fluid (CSF), which surrounds and protects the brain and spinal cord while supplying them with nutrients. This sample is obtained through a procedure called a lumbar puncture, performed under local anesthesia. During the procedure, a doctor inserts a thin needle between two lower vertebrae in the lower back to safely collect the necessary amount of CSF.

It’s important to recognize that this is an invasive procedure, which should only be carried out by trained medical professionals. Although a lumbar puncture is generally safe, it does come with some risks, including:

• Headache
• Infection
• Bleeding

For this reason, patients should discuss the procedure with their doctor beforehand to fully understand all the potential risks and benefits.

Where can you have the Borrelia Burgdorferi IgM At test done in cerebrospinal fluid?

You can have this test performed at IntroLab, a private lab in Belgrade. Our lab is equipped with cutting-edge technology and staffed by specialists in bacteriological serology, allowing us to deliver accurate results. To book an appointment, visit our website or call us directly. If you have any questions or concerns, we’re happy to help.